Stoneridge Investment Partners’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-864	Closed	-$37K	–	210
2017 Q4	$37K	Hold	864	–	–	0.01%	218
2017 Q3	$37K	Hold	864	–	–	0.01%	235
2017 Q2	$32K	Sell	864 -1,433	-62%	-$63.4K	﹤0.01%	248
2017 Q1	$124K	Sell	2,297 -795	-26%	-$41.4K	0.02%	299
2016 Q4	$164K	Hold	3,092	–	–	0.02%	274
2016 Q3	$187K	Sell	3,092 -14	-0.5%	-$872	0.03%	249
2016 Q2	$205K	Sell	3,106 -7,031	-69%	-$446K	0.03%	256
2016 Q1	$575K	Sell	10,137 -1,156	-10%	-$130K	0.08%	196
2015 Q4	$2.66M	Sell	11,293 -2,770	-20%	-$604K	0.36%	91
2015 Q3	$2.22M	Buy	14,063 +2,174	+18%	+$615K	0.31%	101
2015 Q2	$4.5M	Sell	11,889 -2,514	-17%	-$998K	0.56%	43
2015 Q1	$6.02M	Buy	14,403 +115	+0.8%	+$41.1K	0.71%	37
2014 Q4	$3.91M	Buy	14,288 +2,377	+20%	+$591K	0.51%	67
2014 Q3	$2.32M	Sell	11,911 -10	-0.1%	-$2.18K	0.34%	97
2014 Q2	$2.92M	Buy	11,921 +8,624	+262%	+$1.95M	0.44%	74
2014 Q1	$874K	Buy	3,297 +659	+25%	+$252K	0.17%	96
2013 Q4	$958K	Buy	2,638 +1,211	+85%	+$467K	0.18%	91
2013 Q3	$758K	Sell	1,427 -765	-35%	-$262K	0.17%	100
2013 Q2	$513K	Buy	+2,192	New	+$432K	0.12%	102